Correlation Between Inozyme Pharma and Solid Biosciences
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Solid Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Solid Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Solid Biosciences LLC, you can compare the effects of market volatilities on Inozyme Pharma and Solid Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Solid Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Solid Biosciences.
Diversification Opportunities for Inozyme Pharma and Solid Biosciences
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Inozyme and Solid is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Solid Biosciences LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Solid Biosciences LLC and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Solid Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Solid Biosciences LLC has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Solid Biosciences go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Solid Biosciences
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Solid Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Inozyme Pharma is 1.14 times less risky than Solid Biosciences. The stock trades about -0.53 of its potential returns per unit of risk. The Solid Biosciences LLC is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 552.00 in Solid Biosciences LLC on September 1, 2024 and sell it today you would earn a total of 18.00 from holding Solid Biosciences LLC or generate 3.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Solid Biosciences LLC
Performance |
| Timeline |
| Inozyme Pharma |
| Solid Biosciences LLC |
Inozyme Pharma and Solid Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Solid Biosciences
The main advantage of trading using opposite Inozyme Pharma and Solid Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Solid Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Solid Biosciences will offset losses from the drop in Solid Biosciences' long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| Solid Biosciences vs. Century Therapeutics | Solid Biosciences vs. Edgewise Therapeutics | Solid Biosciences vs. C4 Therapeutics | Solid Biosciences vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |